Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Tango Therapeutics
(NASDAQ:TNGX)
Intraday
$7.33
-0.43
[-5.54%]
After-Hours
$7.33
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$7.33
-0.43
[-5.54%]
At close: Apr 25
$7.33
0
[0.00%]
After Hours: 4:20PM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Tango Therapeutics Stock (NASDAQ:TNGX)
Tango Therapeutics Stock (NASDAQ: TNGX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 04, 2024
Cantor Fitzgerald Initiates Coverage On Tango Therapeutics with Overweight Rating
Benzinga Newsdesk
-
Apr 4, 2024, 7:02AM
Wednesday, March 20, 2024
HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Raises Price Target to $17
Benzinga Newsdesk
-
Mar 20, 2024, 6:56AM
Monday, March 18, 2024
Tango Therapeutics shares are trading lower after the company reported worse-than-expected Q4 financial results.
Benzinga Newsdesk
-
Mar 18, 2024, 1:25PM
Recap: Tango Therapeutics Q4 Earnings
Benzinga Insights
-
Mar 18, 2024, 10:05AM
Tango Therapeutics' Cash Position Of $337M As Of December 31, 2023, Combined With $42M In Proceeds From ATM In January 2024 Is Expected To Provide Cash Runway Into Late 2026
Benzinga Newsdesk
-
Mar 18, 2024, 7:44AM
Tango Therapeutics Q4 GAAP EPS $(0.32) Misses $(0.28) Estimate, Sales $5.43M Miss $8.24M Estimate
Benzinga Newsdesk
-
Mar 18, 2024, 7:43AM
Monday, February 12, 2024
Piper Sandler Initiates Coverage On Tango Therapeutics with Overweight Rating, Announces Price Target of $18
Benzinga Newsdesk
-
Feb 12, 2024, 6:43AM
Thursday, January 04, 2024
Medivir's Licensee, Tango Therapeutics Dosed The First Patient With TNG348, A Novel USP1 Inhibitor
Benzinga Newsdesk
-
Jan 4, 2024, 2:59AM
Wednesday, January 03, 2024
Tango Therapeutics Says First Patient Dosed In Phase 1/2 Trial Of TNG348 In Patients With BRCA1/2-Mutant And Other HRD+ Cancers
Benzinga Newsdesk
-
Jan 3, 2024, 7:03AM
Friday, December 08, 2023
B. Riley Securities Initiates Coverage On Tango Therapeutics with Buy Rating, Announces Price Target of $16
Benzinga Newsdesk
-
Dec 8, 2023, 6:10AM
Wednesday, November 08, 2023
Tango Therapeutics: Q3 Earnings Insights
Benzinga Insights
-
Nov 8, 2023, 7:45AM
Tango Therapeutics' Q3 Cash Position Of $360M Provides Cash Runway Into 2026
Benzinga Newsdesk
-
Nov 8, 2023, 7:16AM
Tango Therapeutics Q3 EPS $(0.23) Beats $(0.34) Estimate, Sales $10.73M Beat $7.32M Estimate
Benzinga Newsdesk
-
Nov 8, 2023, 7:15AM
Tuesday, October 17, 2023
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
Lisa Levin
-
Oct 17, 2023, 11:40AM
Monday, October 16, 2023
Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 16, 2023, 1:09PM
Friday, October 13, 2023
Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Oct 13, 2023, 1:14PM
Tango Therapeutics Shares Resume Trade
Benzinga Newsdesk
-
Oct 13, 2023, 10:12AM
Tango Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Down -23.6%
Benzinga Newsdesk
-
Oct 13, 2023, 10:08AM
Thursday, October 12, 2023
Why InMode Shares Are Trading Lower By 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Oct 12, 2023, 12:55PM
Monday, October 09, 2023
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Oct 9, 2023, 1:31PM
Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin
-
Oct 9, 2023, 1:30PM
Monday, September 18, 2023
Tango Therapeutics Plans To Highlight Preclinical Data On Precision Oncology Pipeline At AACR-NCI-EORTC International Conference
Benzinga Newsdesk
-
Sep 18, 2023, 7:05AM
Tuesday, September 12, 2023
Oracle, Sight Sciences And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
-
Sep 12, 2023, 5:40AM
Wednesday, September 06, 2023
The FDA Has Cleared Tango Therapeutics' Investigational New Drug Application For TNG348 For BRCA 1/2 Mutant And Other HRD+ (Homologous Recombination Deficient) Cancers
Benzinga Newsdesk
-
Sep 6, 2023, 7:23AM
Thursday, August 31, 2023
Industry ETFs In The Spotlight: August's Winners And Losers Revealed: Where Is Gold, Energy And Biotech?
Piero Cingari
-
Aug 31, 2023, 12:48PM
Tuesday, August 29, 2023
HEICO, Canaan And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Lisa Levin
-
Aug 29, 2023, 6:27AM
Friday, August 11, 2023
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Lisa Levin
-
Aug 11, 2023, 1:47PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Aug 11, 2023, 1:31PM
5 ETFs Responding To PPI Surge And Consumer Sentiment Dip On Friday
Piero Cingari
-
Aug 11, 2023, 12:47PM
Consolidated Water, Spectrum Brands, Arco Platform, Semler Scientific And Other Big Stocks Moving Higher On Friday
Lisa Levin
-
Aug 11, 2023, 11:14AM
Tango Therapeutics shares are trading higher after HC Wainwright & Co maintained a Buy rating on the stock and raised its price target from $11 to $16.
Benzinga Newsdesk
-
Aug 11, 2023, 11:13AM
HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Raises Price Target to $16
Benzinga Newsdesk
-
Aug 11, 2023, 6:49AM
Thursday, August 10, 2023
Tango Therapeutics shares are trading lower as the stock pulls back after gaining on Wednesday. The company announced a PIPE financing with gross proceeds of $80 million.
Benzinga Newsdesk
-
Aug 10, 2023, 12:40PM
Tango Therapeutics Has Announced 15.5M Private Investment In Public Equity Financing, At $5.15/Share With Gross Proceeds Of $80M
Benzinga Newsdesk
-
Aug 10, 2023, 7:43AM
Wednesday, August 09, 2023
Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session
Lisa Levin
-
Aug 9, 2023, 3:17PM
Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday
Lisa Levin
-
Aug 9, 2023, 2:03PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
-
Aug 9, 2023, 1:31PM
Nasdaq Down 1%; Decibel Therapeutics Shares Spike Higher
Lisa Levin
-
Aug 9, 2023, 12:25PM
Tango Therapeutics shares are trading higher on abnormally-high volume. Not seeing any company-specific news to justify the price action.
Benzinga Newsdesk
-
Aug 9, 2023, 10:15AM
US Stocks Edge Lower; Charles River Earnings Top Estimates
Lisa Levin
-
Aug 9, 2023, 10:09AM
Tango Therapeutics Shares Resume Trading
Happy Mohamed
-
Aug 9, 2023, 10:04AM
Tango Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 136.8%
Happy Mohamed
-
Aug 9, 2023, 10:00AM
Tango Therapeutics Shares Resume Trade
Benzinga Newsdesk
-
Aug 9, 2023, 9:45AM
Tango Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 70.8%
Benzinga Newsdesk
-
Aug 9, 2023, 9:42AM
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
-
Aug 9, 2023, 9:06AM
Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
Lisa Levin
-
Aug 9, 2023, 8:15AM
Tuesday, August 08, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
-
Aug 8, 2023, 5:32PM
HC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $11 Price Target
Benzinga Newsdesk
-
Aug 8, 2023, 6:23AM
Monday, August 07, 2023
Tango Therapeutics shares are trading higher after the company reported Q2 financial results.
Benzinga Newsdesk
-
Aug 7, 2023, 8:11AM
Tango Therapeutics Q2 EPS $(0.23) Up From $(0.28) YoY; Q2 Cash, Cash Equivalents And Marketable Securities Of $310.7M, Expected To Be Sufficient To Fund Operations Into 2026
Benzinga Newsdesk
-
Aug 7, 2023, 7:18AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch